Does Counting Adult Tissue Stem Cells Have a Human Impact?
Asymmetrex’s 3-month campaign to increase awareness of the adult tissue stem cell counting problem has focused on how its AlphaSTEM technology solution could impact research and clinical practice. Now, the final post in the series answers the question, “Does counting adult tissue stem cells have a human impact?”
Today on RegMedNet, Asymmetrex posted its final comment in a 6-expose series to increase awareness among the international regenerative medicine community of the importance of counting adult tissue stem cells for several different areas of stem cell medicine, drug development, and tissue stem cell research. The final post emphasizes the immediate human impact of adoption of the company’s new AlphaSTEM technology. As highlighted on the Asymmetrex website this week, one of the most significant impacts of counting adult tissue stem cells would be immediately starting to reduce the loss and anguish currently endured by families of children treated for leukemia with cord blood samples that may have insufficient blood stem cells for their survival. Now, the simple act of counting the number of blood stem cells in these samples would make the deaths of many children with this dreaded disease avoidable; and it would free waiting families from the distress and fear that their child might be fated to die because before it was not possible to tell if a cord blood sample had sufficient stem cells. Find more information on the greater human impact of adult tissue stem cell counting on the RegMedNet site.
As its founder and current Director, Dr. Sherley leads Asymmetrex with a mission of advancing emerging adult stem cell tissue technologies to applications in clinical drug discovery and cellular medicine. Asymmetrex is the developer and holder of a rich portfolio of recently issued patents for biotechnologies for the quantification and production of human adult tissue stem cells.